November 12, 2026 · Journal of the American College of Cardiology · DOI: 10.1016/j.jacc.2026.10.007

Left Atrial Appendage Closure in Patients Considered Unsuitable for Oral Anticoagulation: Randomized Outcomes Through 5 Years in ASAP-TOO.

Listen to this summary

The ASAP-TOO trial asked whether left atrial appendage closure (LAAC) with the Watchman device is a safe and effective alternative to standard antithrombotic care in atrial fibrillation patients who are deemed unsuitable for oral anticoagulation. In this prematurely terminated, underpowered randomized trial of 481 patients, LAAC was successfully implanted in 97.8% of attempts and showed a numerically lower rate of ischemic stroke or systemic embolism over up to 5 years (7.8% vs 11.4%, not statistically significant), but major bleeding was higher, particularly in the first 3 months, likely due to the mandated antiplatelet regimen. The authors conclude that these exploratory findings are imprecise and should be interpreted cautiously alongside contemporary evidence and shared decision-making.

Vivek Y Reddy, Maurice Buchbinder, Devi G Nair, Ziad F Issa, Timothy R Betts, Boris Schmidt, Srinivas R Dukkipati, Martin W Bergmann, David R Holmes, Kenneth C Huber, Michael L Main, Kristine Roy, Thomas Christen, Brad S Sutton, Kenneth M Stein, Jacqueline Saw

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play